Evolocumab to Reduce Cardiovascular Events in Patients With Diabetes Without Known Significant Atherosclerosis. Huang J. JAMA 2026 Jul 23. doi: 10.1001/jama.2026.10549.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang J. Evolocumab to Reduce Cardiovascular Events in Patients With Diabetes Without Known Significant Atherosclerosis. JAMA 2026 Jul 23. doi: 10.1001/jama.2026.10549.
PMID: 42490090